PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34863821-13	2022	Finally, AMPK pathway activation and MMP9 downregulation were also revealed in the sciatic nerves of diabetic mice administrated with lycorine.	lycorine	134-142	matrix metallopeptidase 9	Mus musculus	37-41	
34863821-14	2022	Taken together, lycorine was advised to promote Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation-induced LC3-II transformation in diabetic peripheral neuropathy.	lycorine	16-24	matrix metallopeptidase 9	Mus musculus	103-107	
30565685-0	2019	Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of beta-catenin and matrix metallopeptidase 9.	lycorine	0-8	matrix metallopeptidase 9	Mus musculus	122-147	
30565685-4	2019	Molecular mechanistic studies revealed that lycorine significantly reduced intracellular levels of beta-catenin protein through degradation of the protein via the ubiquitin-proteasome pathway, and decreased the expression of beta-catenin downstream prometastatic matrix metallopeptidase 9 and Axin2 genes.	lycorine	44-52	matrix metallopeptidase 9	Mus musculus	263-288